Evaxion A (EVAX) Assets (2019 - 2026)
Evaxion A's (EVAX) quarterly Assets came in at $23.6 million in Q1 2026, down 6.33% YoY from $25.2 million in Q1 2025, and down 16.78% on a QoQ basis from $28.4 million in Q4 2025.
Evaxion A (EVAX) Assets (2019 - 2026) Analysis & Trends
Evaxion A (EVAX) has 8 years of Assets data on file, last reported at $23.6 million in Q1 2026.
- Quarterly Assets fell 6.33% year-over-year to $23.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.6 million (down 6.33% YoY) and the FY2025 annual result came in at $28.4 million, up 127.54% from the prior year.
- Assets declined to $23.6 million in Q1 2026, from $28.4 million in the prior quarter.
- In the past five years, Assets ranged from a high of $41.1 million in Q1 2022 to a low of $22654.0 in Q1 2024.
- A 5-year average of $21.5 million and a median of $22.2 million in 2022 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets sank 99.89% — and 2025, when it jumped 111310.79%.
- Tracing EVAX's Assets over 5 years: stood at $22.0 million in 2022, then sank by 41.48% to $12.9 million in 2023, then fell by 3.13% to $12.5 million in 2024, then jumped by 127.54% to $28.4 million in 2025, then dropped by 16.78% to $23.6 million in 2026.
- The last three Assets figures came in at $23.6 million (Q1 2026), $28.4 million (Q4 2025), and $29.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn | 2.10 Bn |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn | 25.60 Bn |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - | 19.82 Bn |
| 10 | Evaxion A | 27.06 Mn | 27.06 Mn | - | 23.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.64 Mn |
| Dec 31, 2025 | 28.41 Mn |
| Sep 30, 2025 | 29.74 Mn |
| Jun 30, 2025 | 22.45 Mn |
| Mar 31, 2025 | 25.24 Mn |
| Dec 31, 2024 | 12.49 Mn |
| Jun 30, 2024 | 15.23 Mn |
| Mar 31, 2024 | 22,654.00 |
| Dec 31, 2023 | 12.89 Mn |
| Sep 30, 2023 | 11.94 Mn |
| Jun 30, 2023 | 16.75 Mn |
| Mar 31, 2023 | 20.49 Mn |
| Dec 31, 2022 | 22.03 Mn |
| Sep 30, 2022 | 27.45 Mn |
| Jun 30, 2022 | 34.00 Mn |
| Mar 31, 2022 | 41.08 Mn |
| Dec 31, 2021 | 40.16 Mn |
| Sep 30, 2021 | 24.12 Mn |
| Jun 30, 2021 | 27.66 Mn |
| Mar 31, 2021 | 34.92 Mn |